FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), een toonaangevend bedrijf gespecialiseerd in zeldzame aandoeningen, maakte vandaag bekend dat het primaire eindpunt is voldaan in het Fase 3-gedeelte van de AZURE-1 studie ter beoordeling van brelovitug, een volledig humaan monoklonaal antilichaam in onderzoeksfase dat zich bindt aan HBsAg (hepatitis B-surface-antigeen), voor de behandeling van chronische HDV (chronische hepatitis delta-virus). Deze bekendmaking i
Author: sHq_LoGiNz
FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), azienda leader nel settore delle malattie rare, oggi ha reso noto che l’endpoint primario è stato raggiunto nella parte di Fase 3 dello studio clinico AZURE-1 volto a valutare brelovitug, un anticorpo monoclonale sperimentale completamente umano che si lega all’antigene di superficie dell’epatite B (HBsAg), per il trattamento del virus dell’epatite cronica Delta (HDV). Il testo originale del presente annuncio, red
MINNEAPOLIS–(BUSINESS WIRE)–U.S. Bank doubles down on its commitment to support small business owners with the launch of its U.S. Bank Business EssentialsTM Visa® Card and U.S. Bank Business EssentialsTM Plus Visa Signature® Card. The cards are designed for small business owners looking for straight-forward rewards on their everyday business purchases. Both offer unlimited 2% cash back on eligible purchases, plus the ability to earn higher cash back when paired with qualifying balances in a q
NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NasdaqGS: SMCI). On March 19, 2026, post-market, the U.S. Department of Justice announced the unsealing of an indictment against three individuals associated with the Company, Yih-Shyan Liaw (the Company’s
LONDON–(BUSINESS WIRE)– Re: Macquarie Group Limited USD 30,000,000.00 MATURING: 01-Jul-2030 ISIN: XS3105238953 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 30-Jun-2026 TO 30-Sep-2026 HAS BEEN FIXED AT 4.68 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 30-Sep-2026 WILL AMOUNT TO: USD 11.95 PER USD 1,000.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: United Utilities Water Finance PLC. GBP 33,000,000.00 MATURING: 05-Oct-2057 ISIN: XS1694666535 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 05-Apr-2026 TO 05-Oct-2026 HAS BEEN FIXED AT 0.54 PCT DAY BASIS: ACTUAL/ACTUAL(ISMA) INTEREST PAYABLE VALUE 05-Oct-2026 WILL AMOUNT TO: GBP 88,409.15 PER GBP 33,000,000.00 DENOMINATION
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS). On August 2, 2023, the Company announced its financial results for the quarter ended June 30, 2023, disclosing that it was revising its diluted earnings-per-share (“EPS”) guidance range to $6.53 to $6.75 from $6.90 to $7.1
LONDON–(BUSINESS WIRE)– Re: Nordic Investment Bank USD 292,000,000.00 MATURING: 04-Oct-2027 ISIN: US65562YAL20 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 06-Jul-2026 TO 05-Oct-2026 HAS BEEN FIXED AT 3.97 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 05-Oct-2026 WILL AMOUNT TO: USD 3,205,760.82 PER USD 319,781,000.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: SNB FUNDING LIMITED AUD 20,000,000.00 MATURING: 27-Jun-2033 ISIN: XS2642669043 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 28-Sep-2026 TO 29-Dec-2026 HAS BEEN FIXED AT 6.53 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 29-Dec-2026 WILL AMOUNT TO: AUD 3,289.82 PER AUD 200,000.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: Bank of Scotland PLC EUR 34,000,000.00 MATURING: 31-Dec-2029 ISIN: XS0279078496 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 30-Sep-2026 TO 31-Dec-2026 HAS BEEN FIXED AT 2.76 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 31-Dec-2026 WILL AMOUNT TO: EUR 352.54 PER EUR 50,000.00 DENOMINATION